滋肾育胎丸治疗黄体功能不全所致复发性流产对患者子宫内膜容受性改善效果

Efficacy of the endometrial receptivity improvement of Zishen yutai pill for treating patients with recurrent abortion caused by luteal insufficiency

目的:滋肾育胎丸治疗黄体功能不全所致复发性流产对患者子宫内膜容受性的影响。方法:以2019年6月-2021年3月本院收治的156例黄体功能不全所致复发性流产患者为研究对象,使用简单随机法分为联合组(n=52)、中药组(n=52)、对照组(n=52),对照组予以地屈孕酮片治疗、中药组使用滋肾育胎丸治疗、联合组在对照组基础联合滋肾育胎丸治疗。使用多模态超声评估患者子宫内膜容受性[子宫内膜厚度、内膜体积(EV)、血管血流指数(VFI)]差异,比较治疗前后子宫内膜形态差异,分析妊娠结局差异并比较治疗期间不良反应。结果:治疗后,子宫内膜厚度、EV、VFI 3组均较治疗前上升且联合组高于中药组和对照组(P<0.05),中药组与对照组无差异(P>0.05);子宫内膜形态3组均较治疗前发生显著变化且联合组优于中药组和对照组(P<0.05),中药组与对照组无差异(P>0.05);临床妊娠率联合组(59.6%)高于中药组(32.7%)、对照组(38.4%)(P<0.05),中药组与对照组无差异(P>0.05),再流产、早产率3组无差异(P>0.05);治疗期间3组不良反应无差异(P>0.05)。结论:联合滋肾育胎丸治疗黄体功能不全所致复发性流产对患者子宫内膜容受性改善效果更佳,临床妊娠提高。

Objective:To evaluate the effects of Zishen yutai pill for treating patients with recurrent abortion caused by luteal insufficiency on their endometrial receptivity.Methods:156patients with recurrent abortion caused by luteal insufficiency between June 2019and March 2021were enrolled as the study subjects,and they were divided into three groups(52cases in each group)by using simple randomization method.The patients in group A were treated with dydrogesterone tablets combined with Zishen yutai pill,the patients in group B were treated with Zishen yutai pill,and the patients in group C were treated with dydrogesterone tablets.Multimodal ultrasound was used to evaluate the differences of the endometrial receptivity,such as endometrial thickness,endometrial volume(EV),and vascular flow index(VFI)of the patients in the three groups.The differences of the endometrial morphology of the patients in the three groups were explored before and after treatment.The differences of the pregnancy outcomes and the occurrence of adverse reactions of the patients during treatment in the three groups were analyzed.Results:The values of endometrial thickness,EV,and VFI of the patients in the three groups after treatment had increased significantly,and which of the patients in group A was significantly higher than that of the patients in group B and that of the patients in group C(P<0.05),but which of the patients had no significant difference between group B and group C(P>0.05).The endometrial morphology of the patients in the three groups after treatment had changed significantly,which of the patients in group A was significantly better than that of the patients in group B and in group C(P<0.05),but which of the patients had no significant difference between group B and group C(P>0.05).The clinical pregnancy rate(59.6%)of the patients in group A was significantly higher than that(32.7%)of the patients in group B and that(38.4%)of the patients in group C(P<0.05),but which of the patients had no significant difference between group B and group C(P>0.05).There were no significant differences in the rates of abortion again,preterm birth,and adverse reactions during treatment of the patients among the three groups(P>0.05).Conclusion:Zishen yutai pill combined with dydrogesterone tablets for treating the patients with recurrent abortion caused by luteal insufficiency has better efficacy on the endometrial receptivity of the patients,and which can increase the clinical pregnancy.